Alzheimer's disease

New Alzheimer's prevention trial receives $74.5 million NIH grant
Drugs.com
Sun, 11/17/24 - 09:22 pm
Eli Lilly
Alzheimer's disease
NIH
clinical trials
Eisai wins over European regulators on Alzheimer’s drug Leqembi
BioPharma Dive
Thu, 11/14/24 - 10:28 pm
Eisai
Biogen
Leqembi
Alzheimer's disease
Eisai Cuts Fiscal 2024 Guidance for Biogen-Partnered Leqembi as Sales Disappoint Analysts
BioSpace
Sun, 11/10/24 - 09:27 pm
Eisai
Biogen
Leqembi
earnings
Alzheimer's disease
Eisai dials back forecasts for Alzheimer's drug Leqembi
Pharmaphorum
Fri, 11/8/24 - 11:38 am
Eisai
earnings
Leqembi
Alzheimer's disease
Cassava’s Alzheimer’s drug nears P3 readout, but SEC scandal casts long shadow R&D
Pharmaphorum
Wed, 11/6/24 - 11:35 am
Cassava Biosciences
Alzheimer's disease
SEC
clinical trials
simufilam
Eisai, Biogen eye 2025 approval for Leqembi autoinjector
Pharmaphorum
Fri, 11/1/24 - 10:57 am
Eisai
Biogen
Leqembi
Alzheimer's disease
FDA
UCB's tau drug flunks phase 2 Alzheimer's trial days after Roche's exit from $120M bet
Fierce Biotech
Fri, 11/1/24 - 10:55 am
UCB Pharma
clinical trials
Roche
Alzheimer's disease
bepranemab
Roche’s Alzheimer’s test shows high negative predictive value
Clinical Trials Arena
Thu, 10/31/24 - 09:15 am
Roche
diagnostics
Alzheimer's disease
Elecsys
Roche sees rapid amyloid clearing in Alzheimer's study, adjusts protocol after patient death
Fierce Biotech
Wed, 10/30/24 - 08:47 pm
Roche
Alzheimer's disease
clinical trials
trontinemab
AbbVie doubles down on Alzheimer’s with $1.4B Aliada buy
BioSpace
Mon, 10/28/24 - 11:41 am
AbbVie
M&A
Alzheimer's disease
Aliada Therapeutics
Lilly's Alzheimer's drug gets UK nod, but no NHS funding
Pharmaphorum
Wed, 10/23/24 - 11:26 am
Eli Lilly
Alzheimer's disease
Kisunla
UK
NHS
NICE
Roche tosses out tau prospect, returning rights to UCB 4 years after placing $120M bet
Fierce Biotech
Tue, 10/22/24 - 11:25 am
Roche
UCB Pharma
anti-tau antibodies
bepranemab
Alzheimer's disease
As new Alzheimer’s biomarkers come into play, here’s where the money is going
Pharma Voice
Thu, 10/17/24 - 09:20 am
R&D
funding
Alzheimer's disease
Leqembi's vial design could result in hundreds of millions in annual Medicare waste: study
Fierce Pharma
Mon, 10/14/24 - 11:13 pm
Eisai
Biogen
Leqembi
Alzheimer's disease
Sage continues downslide as Alzheimer’s study fails
BioPharma Dive
Tue, 10/8/24 - 10:00 pm
SAGE Therapeutics
Alzheimer's disease
clinical trials
SAGE-718
Sage scraps Alzheimer's program as dalzanemdor goes 0 for 2, leaving hopes resting on Huntington's
Fierce Biotech
Tue, 10/8/24 - 09:53 am
SAGE Therapeutics
Alzheimer's disease
dalzanemdor
clinical trials
An Alzheimer’s drugmaker is accused of data ‘manipulation.’ Should its trials be stopped?
Pharma Voice
Fri, 10/4/24 - 09:19 am
Cassava Sciences
Alzheimer's disease
data manipulation
Cassava, former execs ink SEC deal to resolve allegations around misleading Alzheimer's data drop
Fierce Biotech
Mon, 09/30/24 - 09:23 am
Cassava Sciences
Alzheimer's disease
SEC
Eli Lilly's Alzheimer's drug approved in Japan
Reuters
Tue, 09/24/24 - 11:39 am
Eli Lilly
Japan
donanemab
Alzheimer's disease
Their Alzheimer’s treatment worked — but shares fell anyway
Pharma Voice
Thu, 08/29/24 - 11:06 am
Cognition Therapeutics
clinical trials
Alzheimer's disease
CT1812

Pages